Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center

References

• Chan -C-C, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16(11):1589–1599. doi:10.1634/theoncologist.2011-0210.
   PubMed Web of Science ®Google Scholar
• Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm. 2004;12(1):7–16. doi:10.1076/ocii.12.1.7.28072.
   PubMed Web of Science ®Google Scholar
• Sen HN, Bodaghi B, Le Hoang P, Nussenblatt R. Primary Intraocular Lymphoma: diagnosis and Differential Diagnosis. Ocul Immunol Inflamm. 2009;17(3):133–141. doi:10.1080/09273940903108544.
   PubMed Web of Science ®Google Scholar
• Fend F, Ferreri AJM, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173:680–692.
   PubMed Web of Science ®Google Scholar
• Hormigo A, Abrey L, Heinemann M-H, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol. 2004;126:202–208.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Singh AD. Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm. 2009;17:69–72.
   PubMed Web of Science ®Google Scholar
• Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27:241–250.
   PubMedGoogle Scholar
• Marchese A, Miserocchi E, Giuffrè C, et al. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze. Br J Ophthalmol. 2019;103:1656–1659.
   PubMed Web of Science ®Google Scholar
• Deák GG, Goldstein DA, Zhou M, et al. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma. JAMA Ophthalmol. 2019;137:194–198.
   PubMed Web of Science ®Google Scholar
• Marchese A, Agarwal A, Miserocchi E, et al. Features of Retinitis-like Lesions in Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2019;30:1–8.
   Google Scholar
• Pang CE, Shields CL, Jumper JM, Yannuzzi LA. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma. Am J Ophthalmol. 2014;158(6):1253–1261. doi:10.1016/j.ajo.2014.08.031.
   PubMed Web of Science ®Google Scholar
• Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ. Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol Lab Med. 2005;129(8):1050–1053. doi:10.1043/1543-2165(2005)129[1050:PITLBL]2.0.CO;2.
   PubMed Web of Science ®Google Scholar
• Cao X, Shen D, Callanan DG, Mochizuki M, Chan -C-C. CallananDGet al. Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol. 2011;89(2):149–154. doi:10.1111/j.1755-3768.2009.01797.x.
   Web of Science ®Google Scholar
• Coupland SE, Anastassiou G, Bornfeld N, et al. Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2005;243(3):189–197. doi:10.1007/s00417-004-0890-2.
   PubMed Web of Science ®Google Scholar
• Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmology. 2015;133(2):191–197.
   PubMed Web of Science ®Google Scholar
• Cicinelli MV, Marchese A, Miserocchi E, et al. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab. Ocul Immunol Inflamm. 2019;8:1–10.
   Google Scholar
• Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: international PCNSL Collaborative Group report. Neurology. 2008;71(17):1355–1360. doi:10.1212/01.wnl.0000327672.04729.8c.
   PubMed Web of Science ®Google Scholar
• Giuliari GP, Hinkle DM, Foster CS. Local treatment for lymphoid malignancies of the eye. Anticancer Agents Med Chem. 2009;9(10):1123–1128. doi:10.2174/187152009789735071.
   PubMed Web of Science ®Google Scholar
• Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106(9):1805–1810. doi:10.1016/S0161-6420(99)90341-X.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Ferreri AJM, Giuffrè C, et al. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA. Retina. 2019;39(4):679–684. doi:10.1097/IAE.0000000000002319.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886–894. doi:10.1016/j.ajo.2008.12.025.
   PubMed Web of Science ®Google Scholar
• Farkas T, Harbour JW, Dávila RM. Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol. 2004;48:487–491. doi:10.1159/000326409.
   PubMed Web of Science ®Google Scholar
• Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmol. 2015;133:191–197.
   PubMed Web of Science ®Google Scholar
• Pulido JS, Johnston P, Nowakowski GS, Allessia C, Raja H. The diagnosis and treatment of primary vitreoretinal lymphoma: a review. Int J Retina and Vitreous. 2018;4:18. doi:10.1186/s40942-018-0120-4.
   PubMedGoogle Scholar
• Barry RJ, Tasiopoulou A, Murray PI, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018;102:1362–1366. doi:10.1136/bjophthalmol-2017-311612.
   PubMed Web of Science ®Google Scholar
• Dalvin LA, Lim LS, Ancona-Lezama D. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: analysis of 70 Patients at a Single Ocular Oncology Center. Asia Pac J Ophthalmol (Phila). 2020;9:110–116. doi:10.1097/APO.0000000000000274.
   PubMed Web of Science ®Google Scholar
• Marchese A, Miserocchi E, Modorati G, Querques G, Bandello F. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy. Retina. 2018;38(7):53–54. doi:10.1097/IAE.0000000000002204.
   Web of Science ®Google Scholar
• Iida T. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol. 2002;120(1):37–42. doi:10.1001/archopht.120.1.37.
   PubMedGoogle Scholar
• Jabbarpoor Bonyadi MH, Ownagh V, Rahimy E, Soheilian M. Giraffe or leopard spot chorioretinopathy as an outstanding finding: case report and literature review. Int Ophthalmol. 2020;9:1405–1412. doi:10.1007/s10792-018-0948-5.
   Google Scholar
• Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood. 2015;126(1):76–79. doi:10.1182/blood-2015-01-620518.
   PubMed Web of Science ®Google Scholar
• Raja H, Salomão DR, Viswanatha DS, et al. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA. Retina. 2016;36(3):624–628. doi:10.1097/IAE.0000000000000996.
   PubMed Web of Science ®Google Scholar
• Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, et al. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction. JAMA Ophthalmol. 2018;136:1098–1104.
   PubMed Web of Science ®Google Scholar
• Frenkel S, Hendler K, Siegal T, Shalom E, Pe’er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. British J Ophthalmol. 2008;92:383–388.
   PubMed Web of Science ®Google Scholar
• Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma. 2006;47:1800–1805.
   PubMed Web of Science ®Google Scholar
• Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol. 2007;18:1851–1855.
   PubMed Web of Science ®Google Scholar
• Castellino A, Pulido JS, Johnston PB, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: a single center experience 1990-2018. Am J Hematol. 2019;94:291–298.
   PubMed Web of Science ®Google Scholar
• Hashida N, Nakai K, Saitoh N, et al. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol. 2014;252:687–693.
   PubMed Web of Science ®Google Scholar